Recombinant multi-species ATP2A1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATP2A1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in muscular excitation and contraction. Mutations in this gene cause some autosomal recessive forms of Brody disease, characterized by increasing impairment of muscular relaxation during exercise. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Oct 2013]
The Alternative Names of target: ATP2A,ATP2A1,Atp2a1,Calcium pump 1,Calcium-transporting ATPase sarcoplasmic reticulum type,Endoplasmic reticulum class 1/2 Ca(2+) ATPase,SERCA1,SR Ca(2+)-ATPase 1,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,Serca1,fast twitch skeletal muscle isoform

Target products collectionGo to ATP2A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0387-Ag-1/ GM-Tg-hg-IP0387-Ag-2 Human ATP2A1 protein Human
GM-Tg-rg-IP0387-Ag-1/ GM-Tg-rg-IP0387-Ag-2 Rat ATP2A1 protein Rat
GM-Tg-mg-IP0387-Ag-1/ GM-Tg-mg-IP0387-Ag-2 Mouse ATP2A1 protein Mouse
GM-Tg-cynog-IP0387-Ag-1/ GM-Tg-cynog-IP0387-Ag-2 Cynomolgus/Rhesus macaque ATP2A1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0387-Ag-1/ GM-Tg-felg-IP0387-Ag-2 Feline ATP2A1 protein Feline
GM-Tg-cang-IP0387-Ag-1/ GM-Tg-cang-IP0387-Ag-2 Canine ATP2A1 protein Canine
GM-Tg-bovg-IP0387-Ag-1/ GM-Tg-bovg-IP0387-Ag-2 Bovine ATP2A1 protein Bovine
GM-Tg-equg-IP0387-Ag-1/ GM-Tg-equg-IP0387-Ag-2 Equine ATP2A1 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0387-Ag-1/ GM-Tg-hg-IP0387-Ag-2; GM-Tg-rg-IP0387-Ag-1/ GM-Tg-rg-IP0387-Ag-2;
GM-Tg-mg-IP0387-Ag-1/ GM-Tg-mg-IP0387-Ag-2; GM-Tg-cynog-IP0387-Ag-1/ GM-Tg-cynog-IP0387-Ag-2;
GM-Tg-felg-IP0387-Ag-1/ GM-Tg-felg-IP0387-Ag-2; GM-Tg-cang-IP0387-Ag-1/ GM-Tg-cang-IP0387-Ag-2;
GM-Tg-bovg-IP0387-Ag-1/ GM-Tg-bovg-IP0387-Ag-2; GM-Tg-equg-IP0387-Ag-1/ GM-Tg-equg-IP0387-Ag-2
Products Name ATP2A1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ATP2A1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATP2A1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.